New Model Reveals Therapeutic Benefits of Chanling Gao in Liver Metastasis

Chanling Gao shows promise in managing liver metastasis from colorectal cancer, a major mortality factor in CRC, opening doors for enhanced treatment strategies.

• A new AI-driven model predicts prognosis using 11 key genes, improving survival prediction over existing methods.
• Patients with low-risk scores displayed a “hot tumor” phenotype, indicating better responses to immunotherapy; high-risk patients showed the opposite.

This model suggests tailored treatment plans based on risk assessment could significantly impact surgical interventions and patient outcomes.

• Targeting the tp53/cdk1/ccnb1 pathway may further enhance therapeutic strategies for CRC-related liver metastasis.